Gabe Siegel

Founder & CEO at Augmentiqs

Gabe Siegel has a diverse work experience spanning over 15 years. Gabe is the Founder & CEO of Augmentiqs, a company that retrofits microscopes into connected devices, offering augmented reality capabilities. Gabe started this role in December 2015 and is still currently involved with the company. Prior to this, Gabe worked as a Marketing & Business Development Manager at Applied Spectral Imaging from September 2013 to December 2014. From February 2011 to August 2013, they were a Marketing Manager at Alma Lasers. Before that, Gabe worked as a Consultant at Signal Business Development from February 2008 to August 2010. Gabe began their career as a Financial Consultant at KPMG from September 2004 to July 2005.

Gabe Siegel attended the University of Haifa from 2007 to 2008, where they obtained their MBA degree with a focus on International Marketing and Management. Prior to that, from 2001 to 2003, they attended DePaul University and earned their BA degree in Accounting and Marketing. Additionally, it is known that they attended Hebrew Theological College, although specific dates and degrees obtained from this institution were not provided.

Location

Haifa, Israel

Links


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Augmentiqs

Augmentiqs is a young company with a big vision.The end goal is an improvement in healthcare outcomes, and the way we’re going to get there is by developing the future of pathology and digital-microscopy technologies.Augmentiqs was started with the input of the world’s leading pathologists, and focuses on developing new technologies thatintegrate with and enhance the pathologist’s workflow.Augmentiqs’ first solution is real-time telepathology and augmented microscopy, enabling online consultations, live collaboration between remote locations and more efficient investigative studies. By bridging a live, online connection between pathologists, Augmentiqs is enabling better clinical outcomes, reduced costs, and more efficient workflow.Augmentiqs’ patent-pending technology integrates with and enhances the capabilities of all existing microscopes, capturing and sharing the live field of view and augmenting the microscope’s optical plane with interactive annotations and other digital markings by both the user and distant viewers.Augmentiqs harnesses its expertise in telecommunications and electro-optics to deliver an ultra-HD telepathology conferencing platform that is cost-effective and intuitive to the user.By integrating with the existing microscope and providing cost-effective collaboration tools, Augmentiqs is ushering in a new era of Smart Pathology.


Industries

Headquarters

Accho, Israel

Employees

1-10

Links